Spyre Therapeutics logo
Spyre Therapeutics
SYRE | NASDAQ
Chart Builder DCF Calculator
$99.37
-$4.63 (-4.45%)
At close: Nov 16, 2026, 4:00 PM ET
$99.37
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET

Spyre Therapeutics Cash Flow Statement

Cash flow statement explained
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
-155.2M -208.02M -338.79M -83.82M -65.8M -80.89M
10M – 744K 1.96M 1.58M 996K
37.61M 44.83M 25.68M 7.11M 8.04M 6.26M
-13.58M -4.3M -5.8M -2.86M 1.58M -2M
-55.73M 10.31M 217.67M 426K 638K 619K
– – – -327K – -213K
-5.93M -4.53M -5.21M -5.5M 1.83M -2.54M
-169.25M -157.41M -99.91M -80.14M -53.72M -75.78M
– – – -38K -573K -4.28M
– – 3.04M – – –
-522.21M -599.25M -166.8M -39.5M -133.08M -129M
371.74M 245.97M 39.9M 96.55M 111.03M 125.68M
7M – 15.48M – – –
-143.48M -353.29M -108.39M 57.01M -22.62M -7.6M
– – -16K -418K -510K -20K
– – – – – –
– – – – – –
-5.41M 5.67M -5.38M 222K 1.9M 816K
309.03M 410.91M 361.08M 42.68M 1.39M 154.51M
-3.7M -99.79M 152.8M 19.44M -74.96M 71.18M
-169.25M -157.41M -99.91M -80.18M -54.29M -80.06M
-206.87M -202.24M -125.59M -87.29M -62.33M -86.31M
– – – -38K – -4.28M
– – – – -573K –
-169.25M -157.41M -99.91M -80.18M -53.72M -80.06M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.